{"news_desk": "Business", "print_page": "", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN and NEIL UNMACK", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}, {"rank": 2, "role": "reported", "firstname": "Neil", "organization": "", "lastname": "UNMACK"}]}, "abstract": null, "type_of_material": "News", "word_count": "413", "lead_paragraph": "Huge hostile deals are usually catnip for arbitrageurs, but the latest battles come with cross-border complexity, antitrust concerns and a poison pill, Robert Cyran and Neil Unmack of Reuters Breakingviews write.", "pub_date": "2015-04-28T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Fear Keeps Traders on Sidelines of Drug Mega-Deals", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "Huge hostile deals are usually catnip for arbitrageurs, but the latest battles come with cross-border complexity, antitrust concerns and a poison pill, Robert Cyran and Neil Unmack of Reuters Breakingviews write.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/04/28/business/dealbook/fear-keeps-traders-on-sidelines-of-drug-mega-deals.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Perrigo Company", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}], "blog": [], "_id": "553e740e38f0d8592c70c108", "source": "The New York Times"}